<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01534858</url>
  </required_header>
  <id_info>
    <org_study_id>OPM-O-H-1102</org_study_id>
    <nct_id>NCT01534858</nct_id>
  </id_info>
  <brief_title>A Prospective, Descriptive Cohort Study With Prontosan® Wound Gel X in Partial and Full Thickness Burns Requiring Split Thickness Skin Grafts</brief_title>
  <official_title>A Prospective, Descriptive Cohort Study With Prontosan® Wound Gel X in Partial and Full Thickness Burns Requiring Split Thickness Skin Grafts</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>B. Braun Ltd. Centre of Excellence Infection Control</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>B. Braun Ltd. Centre of Excellence Infection Control</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the healing of split thickness skin grafts when
      treated with Prontosan® Wound Gel X in patients with partial and full thickness skin burns.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Graft neo-epithelisation</measure>
    <time_frame>29 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to complete epithelization</measure>
    <time_frame>29 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Wound infection</measure>
    <time_frame>29 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Need for re-operation of target wound site</measure>
    <time_frame>29 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>29 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pruritis</measure>
    <time_frame>29 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Erythema</measure>
    <time_frame>29 days</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Burns</condition>
  <arm_group>
    <arm_group_label>Partial and full thickness burns with split thickness grafts</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Prontosan Wound Gel X</intervention_name>
    <description>Prontasan Wound Gel X will be applied topically as a thin layer to the entire grafted area immediately after transplant and with each dressing change.</description>
    <arm_group_label>Partial and full thickness burns with split thickness grafts</arm_group_label>
    <other_name>polihexanide and betaine containing hydrogel</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Partial of full thickness burns requiring split thickness grafts

          -  Target burn wound size 10cm2-1000cm2

          -  Age ≥ 18 years

          -  Ability to read, write and speak German.

          -  Provision of voluntary consent to participate in the study, following a full
             explanation of the nature and purpose of the study, by signing the informed consent
             approved by the Institutional Ethics Committee (IEC) prior to all evaluations.
             Informed consent will be obtained from the patient or by a legal representative if the
             patient is not able/competent to consent. In this case, informed consent will be also
             obtained by the patient when he/she regains competence.

          -  Women of child bearing potential must test negative on standard urine pregnancy test
             and must agree to practice appropriate contraceptive methods for the duration of the
             study (e. g. oral contraceptive, IUD, intra-muscular contraceptive, abstinence).

        Exclusion Criteria:

          -  Target wound has exposed hyaline cartilage

          -  Connective tissue disorder

          -  Previous skin graft failure at target wound site

          -  Total burn surface area ≥ 70%

          -  Infected target wound

          -  Immunosuppression therapy

          -  Chronic hemodialysis

          -  Steroid use

          -  Diabetes (Type I)

          -  Allergy or sensitivity to any of the ingredients in Prontosan® Wound Gel X

          -  Allergy or sensitivity to chlorhexidine

          -  Pregnancy

          -  Simultaneous participation in another clinical trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adrien Daigeler, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Berufsgenossenschaftliches Unfallklinikum Bergmannsheil Bochum</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jurij Kiefer, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Berufsgenossenschaftliche Unfallklinik Ludwigshafen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Adrian Dragu, PD Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinikum St. Georg Leipzig</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Berufsgenossenschaftliche Unfallklinik Ludwigshafen</name>
      <address>
        <city>Ludwigshafen</city>
        <state>Baden-Württemberg</state>
        <zip>67071</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Berufsgenossenschaftliches Unfallklinikum Bergmannsheil</name>
      <address>
        <city>Bochum</city>
        <zip>44789</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum St. Georg</name>
      <address>
        <city>Leipzig</city>
        <zip>44129</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 10, 2012</study_first_submitted>
  <study_first_submitted_qc>February 14, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 17, 2012</study_first_posted>
  <last_update_submitted>September 21, 2015</last_update_submitted>
  <last_update_submitted_qc>September 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 22, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>polyhexanide, polihexanide, PHMB, Prontosan, burns, wounds</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Burns</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polihexanide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

